We are live on ! Find out more
WN

Williams & Novak Portfolio holdings

AUM $151M
1-Year Est. Return 27.43%
This Fund
S&P 500
This Quarter Est. Return
+13.52%
1 Year Est. Return
+27.43%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$151M
AUM Growth
+$17.6M
Cap. Flow
+$6M
Cap. Flow %
3.97%
Top 10 Hldgs %
38.49%
Holding
157
New
14
Increased
58
Reduced
43
Closed
11
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADT icon
126
ADT
ADT
$5.24B
$94.5K 0.06%
14,533
-1,208
-8% -$8.29K
TBLA icon
127
Taboola.com
TBLA
$1.35B
$88.7K 0.06%
17,740
-1,600
-8% -$6.99K
PBYI icon
128
Puma Biotechnology
PBYI
$407M
$85.1K 0.06%
10,489
-150
-1% -$1.1K
LAW icon
129
CS Disco
LAW
$248M
$82.9K 0.05%
21,925
+67
+0.3% +$260
WIT icon
130
Wipro
WIT
$18.9B
$81.9K 0.05%
36,416
+9,421
+35% +$20K
EVH icon
131
Evolent Health
EVH
$429M
$78.5K 0.05%
14,480
-2,650
-15% -$10.2K
DH icon
132
Definitive Healthcare
DH
$71.1M
$65.3K 0.04%
78,610
+47,880
+156% +$43.9K
ARAY icon
133
Accuray
ARAY
$26.8M
$61.4K 0.04%
238,230
+56,200
+31% +$20.9K
MYPS icon
134
PLAYSTUDIOS Inc
MYPS
$78.4M
$58.1K 0.04%
116,500
+5,700
+5% +$2.74K
SBC
135
SBC Medical Group
SBC
$327M
$57.6K 0.04%
18,686
+4,449
+31% +$15.1K
TRIB
136
Trinity Biotech
TRIB
$6.18M
$54.6K 0.04%
4,685
+1,097
+31% +$20.3K
MDXG icon
137
MiMedx Group
MDXG
$635M
$53.5K 0.04%
+13,884
New +$50.7K
HFFG icon
138
HF Foods Group
HFFG
$81.8M
$51.2K 0.03%
36,345
-4,170
-10% -$8.07K
BTMD icon
139
Biote Corp
BTMD
$70.7M
$43.3K 0.03%
22,910
-8,500
-27% -$17.5K
EGHT icon
140
8x8 Inc
EGHT
$262M
$38.6K 0.03%
22,580
-6,268
-22% -$12.6K
CMRC
141
Commerce.com Inc Series 1
CMRC
$234M
$37.6K 0.02%
+12,700
New +$36.4K
CERS icon
142
Cerus
CERS
$615M
$36.6K 0.02%
12,550
+145
+1% +$352
SIEB icon
143
Siebert Financial
SIEB
$68M
$36.1K 0.02%
21,900
+6,100
+39% +$11.1K
CNDT icon
144
Conduent
CNDT
$234M
$15K 0.01%
10,265
-5,000
-33% -$7.76K
MYSZ icon
145
My Size
MYSZ
$1.93M
$12.6K 0.01%
28,005
+975
+4% +$541
SNYR
146
Synergy CHC Corp
SNYR
$2.5M
$1.99K ﹤0.01%
10,020
-1,925
-16% -$681
AMGN icon
147
Amgen
AMGN
$203B
-732
Closed -$259K
ARES icon
148
Ares Management
ARES
$28.8B
-2,000
Closed -$212K
AVNS icon
149
Avanos Medical
AVNS
$1.17B
-26,348
Closed -$371K
BP icon
150
BP
BP
$109B
-6,008
Closed -$277K

Similar funds

Williams & Novak's Q2 2026 Portfolio in Review

As of Q2 2026, Williams & Novak held 157 positions worth $151M, up 13% from $134M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Williams & Novak deployed $6M of net new capital in Q2 2026, opening 14 new positions and adding to 58 existing holdings. Its largest new stake was Eli Lilly: 423 shares worth $507K.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 8.8% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Fidelity Total Bond ETF, an estimated $1.52M trimmed.

  • Williams & Novak's largest Q2 2026 buy was Eli Lilly: 423 shares worth $507K.
  • Williams & Novak added most to iShares International Small Cap Equity Factor ETF in Q2 2026, an estimated $2.29M increase.
  • Williams & Novak's biggest Q2 2026 reduction was Fidelity Total Bond ETF, cutting an estimated $1.52M.
  • Williams & Novak fully exited NextEra Energy in Q2 2026, selling an estimated $398K.
  • Williams & Novak's ten largest holdings make up 38% of its $151M portfolio in Q2 2026.
  • Williams & Novak opened 14 new positions and closed 11 in Q2 2026.
  • Williams & Novak's portfolio value rose 13% quarter-over-quarter to $151M.

Based on Williams & Novak's 13F filing for Q2 2026, filed 8 Jul 2026.